
Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition: Implication for Bortezomib (VELCADE, PS-341) as a Therapeutic Agent for Malignant Melanoma
Amiri, K. I.Volume:
64
Langue:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-04-0673
Date:
July, 2004
Fichier:
PDF, 458 KB
english, 2004